Lucentis News
Most Popular Lucentis Story
Genentech hiring researchers in big R&D push
Genentech appears poised to announce 70 percent revenue growth for 2006, a monumental increase for a company that started out 30 years ago as a small biotech operation. The huge growth is due to new sales of Lucentis with expanding markets for Avastin, …
... Read more...Latest Headlines
- November 28, 2007
- October 12, 2007
- August 28, 2007
- January 9, 2007
- November 6, 2006
- July 5, 2006
- July 2, 2006
- July 2, 2006
- February 28, 2006
- December 22, 2005
- December 8, 2005
- November 10, 2005
- November 7, 2005
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
